Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011

被引：46

作者：

Jordan, M. R. ^{[1
,2
]}

Bennett, D. E. ^{[3
]}

Wainberg, M. A.

Havlir, D. ^{[4
]}

Hammer, S. ^{[5
]}

Yang, C. ^{[3
]}

Morris, L. ^{[6
]}

Peeters, M. ^{[7
,8
]}

Wensing, A. M. ^{[9
]}

Parkin, N. ^{[10
]}

Nachega, J. B. ^{[11
,12
]}

Phillips, A. ^{[13
]}

De Luca, A. ^{[14
,15
]}

Geng, E. ^{[4
]}

Calmy, A. ^{[16
,20
]}

Raizes, E. ^{[3
]}

Sandstrom, P. ^{[17
]}

Archibald, C. P. ^{[17
]}

Perriens, J.

McClure, C. M.

Hong, S. Y. ^{[2
]}

McMahon, J. H. ^{[2
,18
]}

Dedes, N. ^{[19
]}

Sutherland, D. ^{[17
]}

Bertagnolio, S.

机构：

[1] World Hlth Org, Dept HIV, CH-1211 Geneva 27, Switzerland

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] US Ctr Dis Control & Prevent, Atlanta, GA USA

[4] Univ Calif San Francisco, San Francisco, CA 94143 USA

[5] Columbia Univ, Med Ctr, New York, NY USA

[6] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa

[7] Inst Rech Dev, UMI 233 TransVIHMI, Montpellier, France

[8] Univ Montpellier I, F-34006 Montpellier, France

[9] Univ Med Ctr Utrecht, Utrecht, Netherlands

[10] Data First Consulting, Belmont, CA USA

[11] Univ Stellenbosch, Cape Town, South Africa

[12] Johns Hopkins Bloomberg, Sch Publ Hlth, Baltimore, MD USA

[13] UCL, London WC1E 6BT, England

[14] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Rome, Italy

[15] Siena Univ Hosp, Div Infect Dis, Siena, Italy

[16] Univ Hosp Geneva, Geneva, Switzerland

[17] Publ Hlth Agcy Canada, Ottawa, ON, Canada

[18] Alfred Hosp, Melbourne, Vic, Australia

[19] Int Treatment Preparedness Coalit, Bangkok, Thailand

[20] Med Sans Frontiere Access Campaign, Geneva, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2012年 / 54卷

基金：

比尔及梅琳达.盖茨基金会; 美国国家卫生研究院;

关键词：

EARLY-WARNING INDICATORS; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; GENERIC PROTOCOL; PREGNANT-WOMEN; SURVEILLANCE; INDIVIDUALS; ADHERENCE; CLINICS; PREDICTORS;

D O I：

10.1093/cid/cis206

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

引用

页码：S245 / S249

页数：5

共 50 条

[41] Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings
Brenner, Bluma G.
Ibanescu, Ruxandra-Ilinca
Hardy, Isabelle
Roger, Michel
VIRUSES-BASEL, 2018, 10 (01):
[42] HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update
Lunar, Maja M.
Lepej, Snjezana Zidovec
Tomazic, Janez
Vovko, Tomaz D.
Pecavar, Blaz
Turel, Gabriele
Maver, Manja
Poljak, Mario
PLOS ONE, 2018, 13 (04):
[43] Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe
Ciaranello, Andrea L.
Perez, Freddy
Engelsmann, Barbara
Walensky, Rochelle P.
Mushavi, Angela
Rusibamayila, Asinath
Keatinge, Jo
Park, Ji-Eun
Maruva, Matthews
Cerda, Rodrigo
Wood, Robin
Dabis, Francois
Freedberg, Kenneth A.
CLINICAL INFECTIOUS DISEASES, 2013, 56 (03) : 430 - 446
[44] The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action
Bertagnolio, Silvia
Beanland, Rachel L.
Jordan, Michael R.
Doherty, Meg
Hirnschall, Gottfried
JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S801 - S804
[45] EVALUATION OF THE WORLD-HEALTH-ORGANIZATION ANTIBODY-TESTING STRATEGY FOR THE INDIVIDUAL PATIENT DIAGNOSIS OF HIV-INFECTION (STRATEGY-III)
MARTIN, DJ
BLACKBURN, NK
OCONNEL, KF
BRANT, ET
GOETSCH, EA
SOUTH AFRICAN MEDICAL JOURNAL, 1995, 85 (09): : 877 - 880
[46] Oral Antiretroviral Drugs as Public Health Tools for HIV Prevention: Global Implications for Adherence, Drug Resistance, and the Success of HIV Treatment Programs
Gupta, Ravindra K.
Wainberg, Mark A.
Brun-Vezinet, Francoise
Gatell, Jose M.
Albert, Jan
Sonnerborg, Anders
Nachega, Jean B.
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 : S101 - S106
[47] Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines
Fokam, Joseph
Takou, Desire
Santoro, Maria Mercedes
Akonie, Haniel Ze
Kouanfack, Charles
Ceccherini-Silberstein, Francesca
Colizzi, Vittorio
Perno, Carlo-Federico
Ndjolo, Alexis
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (04) : 329 - 333
[48] Prediction of Treatment Failure Using 2010 World Health Organization Guidelines Is Associated With High Misclassification Rates and Drug Resistance Among HIV-Infected Cambodian Children
Westley, Benjamin P.
DeLong, Allison K.
Tray, Chhraing S.
Sophearin, Dim
Dufort, Elizabeth M.
Nerrienet, Eric
Schreier, Leeann
Harwell, Joseph I.
Kantor, Rami
CLINICAL INFECTIOUS DISEASES, 2012, 55 (03) : 432 - 440
[49] VALIDATION OF THE PROPOSED WORLD-HEALTH-ORGANIZATION STAGING SYSTEM FOR HIV DISEASE AND INFECTION IN A COHORT OF INTRAVENOUS-DRUG-USERS
AYLWARD, RB
VLAHOV, D
MUNOZ, A
RAPITI, E
AIDS, 1994, 8 (08) : 1129 - 1133
[50] Assessment of Drug Prescription Pattern in Mekelle General Hospital, Mekelle, Ethiopia, Using World Health Organization Prescribing Indicators
Yilma, Zewdu
Liben, Mesfin
BIOMED RESEARCH INTERNATIONAL, 2020, 2020

← 1 2 3 4 5 →